Objectives: The postoperative left ventricular end-systolic volume index and ejection fraction are benchmarks of surgical ventricular reconstruction but remain unpredictable. This study aimed to identify who could be associated with a higher long-term survival by adding surgical ventricular reconstruction to coronary artery bypass grafting than coronary artery bypass grafting alone (responders to surgical ventricular reconstruction).
Results: Surgical ventricular reconstruction was performed in 165 patients (56%). The end-systolic volume index and ejection fraction significantly improved (end-systolic volume index, 91 to 64 mL/m 2 ; ejection fraction, 28% to 35%) for all patients. The postoperative end-systolic volume index and ejection fraction were estimated, and surgical ventricular reconstruction was found to be significantly associated with both end-systolic volume index (14.5 mL/m 2 reduction, P<.001) and ejection fraction (3.1% increase, P ¼ .003). During the median follow-up of 6.8 years, 69 patients (24%) died. Only the postoperative ejection fraction was significantly associated with survival (hazard ratio, 0.925; 95% confidence interval, 0.885-0.968), although this effect was limited to those with postoperative end-systolic volume index of 40 to 80 mL/m 2 in the subgroup analysis (hazard ratio, 0.932; 95% confidence interval, 0.894-0.973). 9  12  18  20  29  35  42  2  21  30  50  54  63  71  75  2  7  12  26  37  49  59  81  4  15  20  34  45  62  80  95 Postoperative ESVI and EF were associated with survival after CABG AE SVR.
Central Message
Because SVR could provide survival benefit by improving EF for those with postoperative ESVI within a specific range, responders to SVR could be identified by estimating postoperative ESVI.
The ideal candidate for surgical ventricular reconstruction (SVR) has not been identified because the survival benefit of adding SVR to coronary artery bypass grafting (CABG) for those with ischemic heart disease remains unproven. 1 Volume reduction of the left ventricle (LV) is one of the goals of SVR because the dilated LV after myocardial infarction predicts mortality. 2 Postoperative LVend-systolic volume index (ESVI) less than 60 mL/m 2 , greater than 30% ESVI reduction, and greater than 33% ESVI reduction with a resultant postoperative ESVI less than 90 mL/m 2 are considered to be desired goals of SVR, because these are associated with lower mortality rates after SVR. [3] [4] [5] On the other hand, the postoperative ESVI less than 70 mL/m 2 could demarcate candidates for SVR, because this is associated with a higher survival for those with CABG plus SVR than those with CABG alone. 4 However, the volume reduction effect by SVR has limits. The maximum values of preoperative LV sizes to achieve postoperative ESVI less than 60 mL/m 2 are 65 mm for LV end-diastolic diameter and 94 mL/m 2 for ESVI. 3 On the other hand, because the LV volume reduction by SVR may cause a decrease of stroke volume, 6 a sufficient LV ejection fraction (EF) should be preserved postoperatively. Otherwise, reduced LV stroke volume results in low output syndrome. 7 Although SVR was reported to improve EF with a reduction of the LV volume, 6, 8 the postoperative values of such parameters vary depending on each patient's condition. This makes it difficult to identify who would benefit from SVR, because there remains no method to estimate the postoperative ESVI and EF after SVR specifically and individually. Therefore, we hypothesized that elucidation of the specific effects of SVR on ESVI and EF could make it possible to estimate the postoperative ESVI and EF, and this could help identify who would be associated with a higher long-term survival by adding SVR to CABG than CABG alone (ie, responder to SVR). Thus, this study aimed to identify the responders to SVR by elucidating the relationships among SVR, postoperative ESVI, EF, and survival.
MATERIALS AND METHODS
We conducted a retrospective multicenter study to investigate the effects of SVR on postoperative ESVI, EF, and survival in those who underwent CABG for ischemic heart disease with LV dysfunction (EF 40% in any modality). We used data from a dedicated database, the SURgical VentrIcular reconstruction for severe VEntricular dysfunction (SURVIVE) registry database, which was constructed to collect data on patients with heart failure and LV systolic dysfunction who had undergone cardiac surgery in 17 hospitals in Japan since 1999. Among 1701 patients registered, 1385 underwent CABG for ischemic heart disease. Although 414 patients who had complete datasets of preoperative and postoperative LV volume were candidates, another 121 were excluded considering the bias of LV volume measurement and diversity of surgical procedures. The Bland-Altman analysis was performed to determine the magnitude and directions of intermodality bias for the ESVI and EF using limits of agreement (defined as AE1.96 standard deviation from the mean difference) in patients who had data from multiple modalities. 9 Then, the ESVI and EF of quantitative gated single photon computed emission tomography, left ventriculography, and 2-dimensional echocardiography were compared with magnetic resonance imaging (MRI) as the reference standard, and a considerable bias was found between 2-dimensional echocardiography and other modalities ( Figure E1 ). Then, those with data only from 2-dimensional echocardiography were excluded from the study, and other modalities were selected in the following order for those with multiple modality data: MRI, quantitative gated single photon computed emission tomography, and left ventriculography. Moreover, those with surgical procedures that had been performed for the small number of patients (eg, mitral valve [MV] replacement, chordal cutting, LV linear closure, and SVR without anterior wall incision) were excluded. Finally, the study subjects were 293 patients who underwent CABG for ischemic heart disease between November 1999 and September 2015 (Figure 1) , and the complete datasets of the preoperative and postoperative ESVI and EF from the same modality were acquired from MRI, quantitative gated single photon computed emission tomography, and left ventriculography for 49 patients (17%), 35 patients (12%), and 209 patients (71%), respectively. Completeness of follow-up was calculated at each time point using a simplified person-time method. 10 The median follow-up was 6.8 years (interquartile range [IQR], 3.2-9.8 years), and the rates of complete follow-up at 3 years, 5 years, and 10 years were 90%, 85%, and 73%, respectively. Mortality was detected on the basis of medical records or follow-up inquiries to the attending cardiologists that were made in each hospital. The study protocol was approved by the institutional review boards of all the participating hospitals, and the requirement for obtaining informed consent was waived. 
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Procedures
All SVR procedures included in this study had anterior wall incision, and the types of procedure were selected on the basis of the surgeons' preferences. They comprised endoventricular circular patch plasty 11 for 73 patients (25%), septal anterior ventricular exclusion 12 for 54 patients (18%), overlapping left ventriculoplasty 13 for 21 patients (7%), and an endocardial linear infarct exclusion technique 14 for 17 patients (6%). The endoventricular patch was used in the former 2 procedures but not in the latter 2. MV repair was performed in 100 patients (34%). Forty-seven patients (16%) underwent submitral procedures, including papillary muscle approximation in 43 patients (15%) and papillary muscle suspension in 18 patients (6%) (Video 1). The annuloplasty ring for MV repair was generally downsized but was true-sized for some of those with submitral procedures.
Statistical Analysis
Continuous variables were expressed as mean AE standard deviation when normally distributed or medians with IQRs when not normally distributed. All continuous variables were tested for normality using the Shapiro-Wilk test. The categoric variables were expressed as numbers and percentages. Those with missing data for variables used were dropped from each analysis. Student and paired t tests were used for comparisons of normally distributed variables, whereas the Mann-Whitney U test and Wilcoxon signed-rank test were performed for unpaired and paired data without normal distribution, respectively. Categoric variables were compared using the chi-square test or Fisher exact test, as appropriate. The standardized difference (Cohen's d) was calculated for each variable in comparison between those with and without SVR. 15 Correlations between variables were assessed using Pearson's correlation coefficients (r) when normally distributed or Spearman's rank correlation coefficients (r s ) when not normally distributed. Survival analysis was performed using the Kaplan-Meier method, wherein those who were lost to follow-up were 
censored at the date of their latest follow-up. We hypothesized that adding SVR to CABG could result in a significant reduction of ESVI and increase of EF; the ESVI reduction and EF increase could provide a survival benefit; therefore, adding SVR to CABG could improve the postoperative survival. However, because it is considered that SVR is not always beneficial regardless of the extent of LV remodeling, 16 we also hypothesized that the effect of SVR has the upper and lower limits, which could be indicated by the extent of LV remodeling and demarcate the responders to SVR. Therefore, the analyses were performed in the following order. First, the multiple linear regression analysis was performed with the stepwise method (P <.10) to estimate the postoperative ESVI and EF, taking into account the contribution of SVR (Appendix E1). Second, the Cox regression analysis was performed to elucidate the effect of postoperative ESVI and EF on survival, where continuous variables were natural log transformed when not normally distributed (Appendix E2). In this analysis, propensity score was calculated and entered into the multivariable Cox proportional hazards model to reduce the treatment bias, taking into account the observational nature of this study; the probability of receiving SVR for each patient was calculated using multivariable logistic regression analysis (Appendix E3). Variables for all the multivariable analyses were selected considering their confounding and clinical relevance as well as multicollinearity (variance inflation factor <5.0). Finally, subgroup analysis using Cox proportional hazards models were performed to determine the upper and lower limits in the effect of SVR. All analyses were performed using IBM SPSS Statistics (version 24, IBM Corp, Armonk, NY). Table 1 shows the baseline characteristics and surgical data. The median age was 63 years (IQR, 57-71 years), and 255 patients (87%) were men. The preoperative ESVI and EF were 91 mL/m 2 (IQR, 66-128 mL/m 2 ) and 28% (IQR, 20%-34%), respectively; there was a significant correlation between them (r s ¼ À0.746, P < .001) ( Figure E2 ). The percentage of viable segments in the LV myocardium was obtained in 126 patients (43%) using MRI (52%) and scintigraphy (48%). The median percent viability values were 69% (IQR, 56%-81%) and 81% (IQR, 69%-94%) for those with and without SVR, respectively (P ¼ .002). There were weak correlations between the percent viability and preoperative ESVI (r s ¼ À0.236, P ¼ .008) and EF (r s ¼ 0.220, P ¼ .013).
RESULTS
Baseline Characteristics and Surgical Data
Estimation of Postoperative End-Systolic Volume Index and Ejection Fraction
The postoperative ESVI and EF were evaluated 15 days (median) after surgery (IQR, 11-20 days), and their values were 64 mL/m 2 in median (IQR, 47-88 mL/m 2 ) and 35% AE 11% (P < .001 compared with the preoperative value for each parameter), respectively. The median ESVI reduction rate (postoperative change divided by preoperative value) was 30% (IQR, 9%-43%) and significantly differed between those with and without SVR (SVR, 37% reduction from 103 mL/m 2 to 65 mL/m 2 , P < .001; no SVR, 16% reduction from 78 mL/m 2 to 62 mL/m 2 , P <.001; P <.001 for SVR vs no SVR). Those with SVR were also associated with a greater increase of postoperative EF (a difference between preoperative and postoperative values) than those without SVR (SVR, 8% increase from 26% to 34%, P <.001; no SVR, 6% increase from 30% to 36%, P <.001; P ¼ .025 for SVR vs no SVR).
The stepwise multiple linear regression analysis identified the following variables that estimated the postoperative ESVI and EF: gender, preoperative ESVI, preoperative EF, LV aneurysm, submitral procedure, SVR for postoperative ESVI and preoperative ESVI, preoperative EF, MV repair, and SVR for postoperative EF (Table 2) . Then, it was ascertained that the best equations to calculate the estimated values of postoperative ESVI and EF for the final sample size of 290 patients were as given below:
Postoperative ESVI ¼ 34. 
Effects of Postoperative End-Systolic Volume Index and Ejection Fraction on Mortality
Of the 293 patients, 69 (24%) died during the study period (25% and 22% of those with and without SVR, respectively, P ¼ .58). The Kaplan-Meier analysis demonstrated that the 3-, 5-, and 10-year survivals were 92%, 87%, and 70%, respectively. postoperative EF was significantly associated with postoperative survival (hazard ratio, 0.925; 95% confidence interval, 0.885-0.968; P ¼ .001). Figure 2 shows a significant difference in survival times among different postoperative EF values. These results suggested that adding SVR to CABG could provide survival benefit by increasing EF.
Upper and Lower Limits in Effects of Surgical Ventricular Reconstruction
Because there was a significant correlation between postoperative ESVI and EF (r s ¼ À0.778, P<.001, Figure E2 ), we performed subgroup analysis to elucidate whether the postoperative ESVI (ie, the extent of LV remodeling) limited the effect of EF on survival. As a result, it was found that postoperative EF was significantly associated with survival in those with ESVI of 40 to 80 mL/m 2 (hazard ratio, 0.932; 95% confidence interval, 0.894-0.973; P ¼ .001), although it was not in other subgroups (Figure 3 Figure E3 ). The details of the subgroups of postoperative ESVI are shown in Table E1 .
DISCUSSION
We demonstrated that the postoperative EF was significantly associated with survival after CABG with or without SVR, although this association was limited within a specific range of postoperative ESVI. Because SVR could provide a significant reduction of ESVI and increase of EF, adding SVR to CABG could provide a survival benefit by increasing EF for the selected patients regarding postoperative ESVI. Thus, estimating postoperative ESVI could help identify who would benefit from CABG plus SVR compared with CABG alone.
In this study, we found that SVR was one of the variables that were significantly associated with the postoperative ESVI and EF: Adding SVR to CABG could result in a 14.5 mL/m 2 reduction of ESVI and a 3.1% increase of EF. On the other hand, although the postoperative ESVI (<60-70 mL/m 2 ) could have predicted a higher survival, 3, 4 only the postoperative EF was identified to be significantly associated with the postoperative survival in the multivariable Cox proportional hazards model. Thus, it was suggested that SVR could provide survival benefit not by reducing ESVI but by increasing EF. Moreover, it was also demonstrated that the absolute value of postoperative EF, rather than the extent of postoperative improvement of EF, was the significant variable. Some previous studies focused on myocardial viability, which could be indicated by the extent of postoperative improvement of EF, as an important predictor of survival after CABG for ischemic heart disease, although it remains controversial. [17] [18] [19] [20] [21] Our results suggested that it could be required for better survival to keep postoperative EF as high as possible, regardless of the postoperative change of this parameter. Therefore, in consideration of whether SVR should be added or not, the perspective that a higher postoperative EF could be estimated with SVR than without it could encourage surgeons to perform the procedure. On the other hand, it is doubted whether all the patients could have survival benefit from SVR by increasing EF, because it is considered that SVR could not change the fate of the extremely deteriorated LV and would not be required for the LV with sufficient ability. 16 Thus, it would be natural that the extent of LV remodeling limited the positive effect of EF increase by SVR on survival.
Because the postoperative EF significantly correlated with ESVI, we conducted subgroup analysis dividing the subjects according to the postoperative ESVI (ie, the extent of LV remodeling) and found that the beneficial effect of postoperative EF was limited to those with postoperative ESVI of 40 to 80 mL/m 2 . Because the IQR of preoperative ESVI in this patient group was 79 to 111 mL/m 2 , this result was consistent with previous reports that suggested that those with mid-range preoperative ESVI were responders to SVR, with ranges of 80 to 120 mL/m 2 reported by Skelley and colleagues, 22 100 to 130 mL/m 2 by Yamazaki and colleagues, 23 and 105 to 150 mL/m 2 by Kainuma and colleagues. 24 Thus, those who are estimated to have the 27  37  57  63  75  86  93  14  13  17  41  50  67  76  91  6  11  18  29  42  60  82  109  8 Postoperative EF > 39% Postoperative EF 30-39% Postoperative EF ≤ 30% P < .001 postoperative ESVI within the target range of 40 to 80 mL/ m 2 could be responders to SVR, because the increase of EF by adding SVR could be beneficial only within this range of ESVI.
On the other hand, it is not simple to identify the responders to SVR, because the postoperative ESVI cannot be estimated by a single effect of SVR. Several factors are involved in the estimation, and the surgical technique is just one of these. Actually, the extent of preoperative LV remodeling (ie, preoperative ESVI and EF) affected ESVI more dominantly. This would be consistent with the previous reports that showed a wide range of perioperative LV volumes and its reduction rates, 22, [25] [26] [27] suggesting that the volume reduction effect of SVR could be affected and the postoperative LV volume could vary depending on the individual condition of each patient. These results also could explain why it is difficult to prove the benefit of SVR by a simple comparison study, such as a randomized controlled trial. 1 SVR may not be a procedure that provides a survival benefit for all patients who undergo CABG for ischemic heart disease. However, because conventional surgery could be an alternative to transplantation and ventricular assist device therapy for highly selected patients, 28 SVR could provide a survival benefit if the indication is carefully determined. On the other hand, the purpose of this study was to identify who could benefit from SVR plus CABG compared with CABG alone, by elucidating the specific effects of SVR on ESVI and EF; this is different from estimating survival time of individual patients if SVR was performed, which we had reported previously. 29 In surgical decision making, we should take into consideration not only the benefit of adding SVR to CABG but also the mortality risk of the entire surgical procedure: long-term survival could not always be expected even if adding SVR improved survival to some extent. For high-risk patients, ventricular assist device and transplantation should be considered even if the postoperative ESVI could be estimated within the target range for SVR (Figure 4 ).
Study Limitations
One of the major limitations of this study was its retrospective design. Selection bias for surgical procedures could have affected our results. Therefore, we calculated the propensity score and entered it into the multivariable model to reduce the bias. Moreover, because the relationship between ESVI and EF was similar between those with and without SVR ( Figure E2 ), we assumed that both LV with or without SVR could be within the same spectrum of LV remodeling, and they could be analyzed as a whole. Second, because our database had a non-negligible amount of missing data for possibly important parameters, such as pulmonary artery pressure, LV diastolic function, and percent viability in the LV, we excluded those parameters from the analyses to defend the sample size, because the analysis, which enrolled the percent viability for less than half of the patients, demonstrated no significant improvement in predictive power of the equations for postoperative ESVI and EF. A prospective study including such parameters with sufficient number of cases will contribute to further clarification by improving the estimation of the postoperative parameters.
CONCLUSIONS
Adding SVR to CABG could provide a survival benefit by increasing EF for those with postoperative ESVI within a specific range. Thus, the postoperative ESVI could demarcate responders to SVR, and the estimation of this parameter can help identify who would benefit from CABG plus SVR rather than CABG alone. In surgical decision making, however, not only the benefit of adding SVR but also the risk of entire procedure should be taken into consideration.
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APPENDIX E1
Postoperative ESVI and EF were estimated using stepwise multiple linear regression analysis based on the following clinically relevant variables without missing values: age, gender, NYHA functional class, inotrope use, preoperative ESVI, preoperative EF, LV aneurysm, number of anastomoses in CABG, MV repair, submitral procedure, and SVR.
APPENDIX E2
The multivariable Cox proportional hazards model for postoperative survival was constructed to elucidate whether the postoperative ESVI and EF would estimate survival. The following variables were selected considering the results of previous studies and the bias for receiving SVR (inclusive of variables with proportion of missing values 3%): SVR, propensity score, postoperative ESVI, postoperative EF, ESVI reduction rate, and increase of EF.
APPENDIX E3
The propensity score was calculated using multivariable logistic regression analysis with the following variables considering their clinical relevance and standardized differences (>0.1), inclusive of variables with proportion of missing values 3% or less: age, gender, number of coronary lesions, left main disease, atrial fibrillation, LV aneurysm, preoperative NYHA functional class, inotrope use, preoperative mitral regurgitation grade, preoperative LV enddiastolic diameter, preoperative ESVI, and preoperative EF. 
